MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Theravance Biopharma Company Profile (NASDAQ:TBPH)

Consensus Ratings for Theravance Biopharma (NASDAQ:TBPH) (?)
Ratings Breakdown: 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $17.00 (35.24% upside)

Analysts' Ratings History for Theravance Biopharma (NASDAQ:TBPH)
Show:
DateFirmActionRatingPrice TargetActions
2/3/2015Robert W. BairdUpgradeUnderperform -> Neutral$13.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2014Leerink SwannInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/14/2014Robert W. BairdDowngradeNeutral -> Underperform$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2014Bank of AmericaInitiated CoverageBuy$34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2014Robert W. BairdInitiated CoverageNeutral$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/2/2013 forward)